Minireviews
Copyright ©The Author(s) 2024.
World J Hepatol. May 27, 2024; 16(5): 766-775
Published online May 27, 2024. doi: 10.4254/wjh.v16.i5.766
Figure 2
Figure 2 Demonstrates immunohistochemical features of combined hepatocellular-cholangiocarcinoma. A: Hep-par1 immunostaining in hepatocellular component (× 5); B: Strong EMA immunostaining in cholangiocarcinoma component (× 3); C: Nestin immunostaining in a combined hepatocellular- cholangiocarcinoma (× 7.5).